Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Oxazolidinone antibacterial agents in development at Zeneca

March 27, 1998

Novel compounds for allergic/inflammatory disorders discovered at Astra

March 27, 1998

New treatments for preterm labor from Merck

March 26, 1998

First report of nonpeptide compounds as MHC class II inhibitors

March 26, 1998

Vacuolar ATPase inhibitors claimed by SmithKline Beecham for osteoporosis

March 26, 1998

Schering AG describes new diagnostics

March 26, 1998

Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan

March 26, 1998

Sumitomo scientists describe new agents for hyperlipidemia

March 26, 1998

Yamanouchi research yields potential new antipsychotic agents

March 26, 1998

Neurogen describes treatment for stress-related disorders

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...